Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
896.00    2.00 (0.22%)
Bid:
894.00
Ask:
900.00
Spread: 6.00 (0.671%)
Market Cap: £487.52m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Dividend Declaration

25 Mar 2026 07:00

RNS Number : 9769X
JPMorgan Claverhouse IT PLC
25 March 2026
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

(the "Company")

 

First quarterly interim dividend

 

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with DTR 6.1.13

 

 

The Directors of the Company have declared that a first quarterly interim dividend of 8.50 pence per share for the year ending 31st December 2026 will be paid on 1st June 2026 to shareholders on the register at the close of business on 24th April 2026. The ex-dividend date will be 23rd April 2026.

 

As announced in the 2025 Annual Report, the Board intends to raise the first three quarterly interim dividends in 2026 to 8.50p per share, from 8.40p per share in the previous financial year, subject to any unforeseen factors, the financial position and performance of the Company at the relevant time.

 

The Company has increased its total annual dividend for 53 consecutive years and the Board's dividend policy remains to seek to increase the dividend each year and, taking a run of years together, to increase dividends at a rate close to or above, the rate of inflation.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Computershare Investor Services plc.

 

The key dates relating to this dividend are given below:

 

Ex-dividend date

23rd April 2026

Record date

24th April 2026

Last date for DRIP election

8th May 2026

Payment date

1st June 2026

 

 

25th March 2026

 

 For further information:

 Anmol Dhillon

 JPMorgan Funds Limited

 Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUUGWUPQGBC
Date   Source Headline
23rd Jan 202411:30 amRNSNet Asset Value(s)
22nd Jan 202412:24 pmRNSGearing Announcement
22nd Jan 202411:11 amRNSNet Asset Value(s)
19th Jan 202411:16 amRNSNet Asset Value(s)
18th Jan 202410:45 amRNSNet Asset Value(s)
18th Jan 20247:00 amRNSDividend Declaration
17th Jan 202410:37 amRNSNet Asset Value(s)
16th Jan 202410:46 amRNSNet Asset Value(s)
15th Jan 202412:12 pmRNSGearing Announcement
15th Jan 202411:07 amRNSNet Asset Value(s)
12th Jan 202411:04 amRNSNet Asset Value(s)
11th Jan 202410:45 amRNSNet Asset Value(s)
10th Jan 202410:42 amRNSNet Asset Value(s)
10th Jan 202410:27 amRNSTen Largest Investments
9th Jan 20244:33 pmRNSNotification of Cross Holding
9th Jan 202410:43 amRNSNet Asset Value(s)
8th Jan 20245:21 pmRNSTransaction in Own Shares
8th Jan 202411:24 amRNSGearing Announcement
8th Jan 202410:19 amRNSNet Asset Value(s)
5th Jan 20245:06 pmRNSTransaction in Own Shares
5th Jan 202410:57 amRNSNet Asset Value(s)
4th Jan 202411:14 amRNSNet Asset Value(s)
3rd Jan 202411:22 amRNSNet Asset Value(s)
2nd Jan 20241:54 pmRNSGearing Announcement
2nd Jan 20241:22 pmRNSNet Asset Value(s)
2nd Jan 202410:46 amRNSTotal Voting Rights
29th Dec 202311:24 amRNSNet Asset Value(s)
28th Dec 20234:58 pmRNSTransaction in Own Shares
28th Dec 202311:27 amRNSNet Asset Value(s)
27th Dec 20235:24 pmRNSTransaction in Own Shares
27th Dec 202312:42 pmRNSGearing Announcement
27th Dec 202311:53 amRNSNet Asset Value(s)
22nd Dec 20231:18 pmRNSTransaction in Own Shares
22nd Dec 202311:08 amRNSNet Asset Value(s)
21st Dec 202310:45 amRNSNet Asset Value(s)
20th Dec 20235:17 pmRNSTransaction in Own Shares
20th Dec 202310:24 amRNSNet Asset Value(s)
19th Dec 202311:29 amRNSNet Asset Value(s)
18th Dec 202311:18 amRNSGearing Announcement
18th Dec 202310:24 amRNSNet Asset Value(s)
15th Dec 202311:18 amRNSNet Asset Value(s)
14th Dec 202310:34 amRNSNet Asset Value(s)
13th Dec 202310:34 amRNSNet Asset Value(s)
13th Dec 202310:33 amRNSDirector/PDMR Shareholding
12th Dec 20236:17 pmRNSTen Largest Investments
12th Dec 202310:19 amRNSNet Asset Value(s)
11th Dec 20235:09 pmRNSTransaction in Own Shares
11th Dec 202311:27 amRNSGearing Announcement
11th Dec 202310:14 amRNSNet Asset Value(s)
8th Dec 20235:09 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.